Opinion – Another global health crisis is gaining momentum. We need to be prepared.
A global health emergency is well underway — and we’re dangerously unprepared to contain it. Drug-resistant infections are…
‘The Karpathy Loop’: 700 experiments, 2 days, and a glimpse of where AI is heading
Earlier this month, Andrej Karpathy, a well-known AI researcher who was one of the founding employees of OpenAI…
China to step up tech, energy and decarbonisation efforts in next 5-year plan
China will set priorities for technological innovation, economic security, public well-being and carbon reduction over the next five…
EU doesn’t need all 27 to move forward on reforms – POLITICO
In Wall Street Journal interview, ECB chief backs smaller country groupings to push capital markets reform and other…
Estonia is linking a super genome database to patient records. Is it safe? – POLITICO
At a time when trust in institutions — including in health care — is being eroded by mis- and…
Cosmo Surges 40% on Baldness Candidate’s Phase III Data
Images of the scalps of two patients treated with the 5% formulation of Cosmo Pharmaceuticals’ androgenetic alopecia (AGA)…
After 1- and 6-Month Gains, Gene Editing Companies Await Q3 Results
As developers of gene editing therapies and other genetic medicines get set to report third quarter earnings in…
SAP cuts dozens of Bay Area jobs as part of new layoff strategy
SAP is laying off 82 Palo Alto employees as part of a global plan for steady, annual job…
This Artificial Intelligence (AI) Stock Will Be the Nvidia of Quantum Computing by 2035
Quantum computing is gaining momentum as the next frontier of artificial intelligence (AI) development. Alphabet has a unique…
SpaceX and satellites help states save millions on internet buildout | Guest Commentary | Commentary
The $42.5 billion Broadband Equity, Access, and Deployment (BEAD) program was meant to bring affordable, reliable internet to…
Sarepta Says Deaths of Two Elevidys Patients Posted on FDA Database Unrelated to Treatment
Sarepta Therapeutics (NASDAQ: SRPT) said Friday that the deaths of two patients taking its marketed gene therapy Elevidys®…